Gilead Sciences stock heads into the open after a 0.4% dip
Published on 09/14/2026 at 05:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gilead Sciences stock closed at USD 143.72 on the Nasdaq on September 11, 2026, down 0.4% from the prior session. The shares traded between USD 142.60 and USD 144.30 during the day, with total volume near recent averages per Nasdaq data at MarketBeat. Compared with the broader Nasdaq Composite, which edged lower by around 0.3% on September 11, 2026 according to Nasdaq data at Yahoo Finance, Gilead Sciences showed a slightly weaker performance. Today the stock moves toward the open ahead of an upcoming USD 0.82 per share ex-dividend date later in September.
September 11, 2026 in numbers
Gilead Sciences Inc. (ISIN US3755581036, Nasdaq: GILD) recorded a modest decline on September 11, 2026 as it closed at USD 143.72 on the Nasdaq after trading within an intraday range of USD 142.60 to USD 144.30, per Nasdaq data referenced by MarketBeat and other quote services. The 0.4% retreat for the session came as the stock followed the broader health care and biotechnology space, where several large constituents also eased alongside a soft Nasdaq Composite close, according to market wrap data from Nasdaq and Yahoo Finance. While no single company specific announcement clearly dominated trading on September 11, 2026, investors continued to factor in the upcoming quarterly dividend and the broader interest rate backdrop that has influenced defensive and income oriented names in recent weeks. Relative to its 52 week range reported on recent quote overviews, the September 11, 2026 close left Gilead Sciences shares in the upper half of their trailing year band, indicating that the stock remains closer to its recent highs than lows despite the latest small pullback.
Dividend focus today
Today, Gilead Sciences is in focus for income oriented investors because the stock is scheduled to go ex dividend later in September. As PayoutCal shows in its ex dividend calendar for the week of September 14, 2026, Gilead Sciences is due to pay a quarterly cash dividend of USD 0.82 per share with an ex dividend date listed in late September 2026. A recent dividend focused note from Moomoo also highlights the upcoming payout, underlining that shareholders of record around mid to late September will qualify for the distribution. Alongside the dividend schedule, Gilead Sciences traders today watch the broader Nasdaq direction and any sector specific news flow in biotechnology and antiviral therapies, as moves in peers and the index can shape sentiment in the stock ahead of the next earnings release, which remains further out on the reporting calendar.
